BVXV Annual CFO
-$7.26 M
+$161.00 K+2.17%
31 December 2022
Summary:
As of February 5, 2025, BVXV annual cash flow from operations is -$7.26 million, with the most recent change of +$161.00 thousand (+2.17%) on December 31, 2022. During the last 3 years, it has risen by +$14.99 million (+67.35%).BVXV Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BVXV Quarterly CFO
-$2.88 M
+$183.00 K+5.98%
30 June 2023
Summary:
As of February 5, 2025, BVXV quarterly cash flow from operations is -$2.88 million, with the most recent change of +$183.00 thousand (+5.98%) on June 30, 2023. Over the past year, it has increased by +$789.00 thousand (+21.53%).BVXV Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BVXV TTM CFO
-$5.93 M
+$789.00 K+11.73%
30 June 2023
Summary:
As of February 5, 2025, BVXV TTM cash flow from operations is -$5.93 million, with the most recent change of +$789.00 thousand (+11.73%) on June 30, 2023. Over the past year, it has dropped by -$1.17 million (-24.42%).BVXV TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BVXV Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +2.2% | +21.5% | -24.4% |
| 3 y3 years | +67.3% | - | - |
| 5 y5 years | -151.2% | +72.5% | - |
BVXV Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +501.7% | +975.1% | +1126.7% |
BiondVax Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | -$2.88 M(-6.0%) | -$5.93 M(-11.7%) |
| Mar 2023 | - | -$3.06 M(-16.5%) | -$6.72 M(+41.0%) |
| Dec 2022 | -$7.26 M(-2.2%) | - | - |
| June 2022 | - | -$3.67 M(+231.7%) | -$4.77 M(+331.7%) |
| Mar 2022 | - | -$1.10 M(-82.1%) | -$1.10 M(-90.8%) |
| Dec 2021 | -$7.43 M(-67.1%) | - | - |
| Dec 2020 | -$22.56 M(+1.4%) | - | - |
| Dec 2019 | -$22.25 M(+46.5%) | - | - |
| June 2019 | - | -$6.17 M(+69.2%) | -$11.98 M(-26.3%) |
| Mar 2019 | - | -$3.65 M(+230.7%) | -$16.25 M(+7.0%) |
| Dec 2018 | -$15.19 M(+425.2%) | -$1.10 M(+3.7%) | -$15.19 M(+5.8%) |
| Sept 2018 | - | -$1.06 M(-89.8%) | -$14.35 M(-0.0%) |
| June 2018 | - | -$10.44 M(+305.0%) | -$14.36 M(+198.2%) |
| Mar 2018 | - | -$2.58 M(+858.4%) | -$4.82 M(+66.5%) |
| Dec 2017 | -$2.89 M | -$269.00 K(-74.8%) | -$2.89 M(-9.2%) |
| Sept 2017 | - | -$1.07 M(+18.8%) | -$3.19 M(+33.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2017 | - | -$899.70 K(+37.5%) | -$2.38 M(+3.1%) |
| Mar 2017 | - | -$654.40 K(+16.3%) | -$2.31 M(-7.9%) |
| Dec 2016 | -$2.51 M(-4.6%) | -$562.50 K(+110.3%) | -$2.51 M(-7.8%) |
| Sept 2016 | - | -$267.50 K(-67.7%) | -$2.72 M(-11.2%) |
| June 2016 | - | -$827.80 K(-2.8%) | -$3.06 M(+2.6%) |
| Mar 2016 | - | -$851.70 K(+10.0%) | -$2.99 M(+13.6%) |
| Dec 2015 | -$2.63 M(+35.3%) | -$774.00 K(+26.8%) | -$2.63 M(+12.4%) |
| Sept 2015 | - | -$610.50 K(-18.8%) | -$2.34 M(+7.0%) |
| June 2015 | - | -$751.50 K(+52.1%) | -$2.19 M(+11.8%) |
| Mar 2015 | - | -$494.10 K(+2.2%) | -$1.95 M(+0.5%) |
| Dec 2014 | -$1.94 M(+61.0%) | -$483.70 K(+5.9%) | -$1.94 M(+33.1%) |
| Sept 2014 | - | -$456.70 K(-12.2%) | -$1.46 M(+45.5%) |
| June 2014 | - | -$520.40 K(+7.6%) | -$1.00 M(+107.6%) |
| Mar 2014 | - | -$483.80 K | -$483.80 K |
| Dec 2013 | -$1.21 M(-35.6%) | - | - |
| Dec 2012 | -$1.88 M(-26.2%) | - | - |
| Dec 2011 | -$2.54 M | - | - |
FAQ
- What is BiondVax Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for BiondVax Pharmaceuticals?
- What is BiondVax Pharmaceuticals annual CFO year-on-year change?
- What is BiondVax Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for BiondVax Pharmaceuticals?
- What is BiondVax Pharmaceuticals quarterly CFO year-on-year change?
- What is BiondVax Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for BiondVax Pharmaceuticals?
- What is BiondVax Pharmaceuticals TTM CFO year-on-year change?
What is BiondVax Pharmaceuticals annual cash flow from operations?
The current annual CFO of BVXV is -$7.26 M
What is the all time high annual CFO for BiondVax Pharmaceuticals?
BiondVax Pharmaceuticals all-time high annual cash flow from operations is -$1.21 M
What is BiondVax Pharmaceuticals annual CFO year-on-year change?
Over the past year, BVXV annual cash flow from operations has changed by +$161.00 K (+2.17%)
What is BiondVax Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of BVXV is -$2.88 M
What is the all time high quarterly CFO for BiondVax Pharmaceuticals?
BiondVax Pharmaceuticals all-time high quarterly cash flow from operations is -$267.50 K
What is BiondVax Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, BVXV quarterly cash flow from operations has changed by +$789.00 K (+21.53%)
What is BiondVax Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of BVXV is -$5.93 M
What is the all time high TTM CFO for BiondVax Pharmaceuticals?
BiondVax Pharmaceuticals all-time high TTM cash flow from operations is -$483.80 K
What is BiondVax Pharmaceuticals TTM CFO year-on-year change?
Over the past year, BVXV TTM cash flow from operations has changed by -$1.17 M (-24.42%)